BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
7.39
+0.17 (2.35%)
Apr 17, 2025, 4:00 PM EDT - Market closed
BioCryst Pharmaceuticals Analyst Ratings
Total Analysts
6
Consensus Rating
Buy
Price Target
$15.67
Upside
+112.04%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $11 | Buy | Reiterates | $11 | +48.85% | Apr 11, 2025 |
| Needham | Needham | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +102.98% | Apr 10, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $18 | Buy | Reiterates | $18 | +143.57% | Mar 3, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $10 → $11 | Buy | Reiterates | $10 → $11 | +48.85% | Feb 25, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $18 | Buy | Reiterates | $18 | +143.57% | Feb 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +305.95% | Feb 25, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +143.57% | Jan 31, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +62.38% | Jan 13, 2025 |
| Needham | Needham | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +102.98% | Jan 13, 2025 |
| Needham | Needham | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +102.98% | Dec 17, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +35.32% | Nov 5, 2024 |
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +89.45% | Nov 5, 2024 |
| Barclays | Barclays | Hold Maintains $7 → $8 | Hold | Maintains | $7 → $8 | +8.25% | Nov 5, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $15 → $16 | Buy | Maintains | $15 → $16 | +116.51% | Aug 6, 2024 |
| Barclays | Barclays | Hold Maintains $6 → $7 | Hold | Maintains | $6 → $7 | -5.28% | Aug 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +35.32% | Aug 6, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.